Siblings 專利 [0/3] 會議論文/會議摘要 [0/2] Collection Statistics 近3年內發表的文件:3(14.29%) 含全文筆數:21(100.00%) 文件下載次數統計 下載大於0次:21(100.00%) 下載大於100次:19(90.48%) 檔案下載總次數:12143(100.00%) 最後更新時間: 2024-11-28 17:56 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Discovery of a long half-life AURKA... Pulmonary delivery of remdesivir an... Modulating the affinity and signali... Synergistic inhibition of SARS-CoV-... Discovery and synthesis of a pyrimi... Synergistic inhibition of SARS-CoV-... Inhibition of SARS-CoV-2 by highly ... Comparative study between deep lear... Fluorine-18 isotope labeling for po... Design and synthesis of BPR1K653 de...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-10 / 21. (共3頁) 1 2 3 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2024-06-01	Discovery of a long half-life AURKA inhibitor to treat MYC-amplified solid tumors as a monotherapy and in combination with everolimus	Molecular Cancer Therapeutics. 2024 Jun 01;23(6):766-779.
2023-12	Pulmonary delivery of remdesivir and dexamethasone encapsulated nanostructured lipid carriers for enhanced inflammatory suppression in lung	Journal of Drug Delivery Science and Technology. 2023 Dec;90:Article number 105144.
2023-01	Modulating the affinity and signaling bias of cannabinoid receptor 1 antagonists	Bioorganic Chemistry. 2023 Jan;130:Article number 106236.
2021-06-11	Synergistic inhibition of SARS-CoV-2 replication using disulfiram/ebselen and remdesivir[Erratum:ACS Pharmacology and Translational Science. 2021 Apr 9;4(2):898-907.]	ACS Pharmacology and Translational Science. 2021 Jun 11;4(3):Article number 1246.
2021-05-19	Discovery and synthesis of a pyrimidine-based aurora kinase inhibitor to reduce levels of MYC oncoproteins	Journal of Medicinal Chemistry. 2021 May 19;64(11):7312-7330.
2021-04-09	Synergistic inhibition of SARS-CoV-2 replication using disulfiram/ebselen and remdesivir	ACS Pharmacology and Translational Science. 2021 Apr 9;4(2):898-907.
2020-12-14	Inhibition of SARS-CoV-2 by highly potent broad-spectrum anti-coronaviral tylophorine-based derivatives	Frontiers in Pharmacology. 2020 Dec 14;11:Article number 606097.
2020-10-08	Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery	Scientific Reports. 2020 Oct 8;10:Article number 16771.
2019-01-01	Fluorine-18 isotope labeling for positron emission tomography imaging. Direct evidence for DBPR211 as a peripherally restricted CB1 inverse agonist	Bioorganic and Medicinal Chemistry. 2019 Jan 1;27(1):216-223.
2018-05-10	Design and synthesis of BPR1K653 derivatives targeting the back pocket of Aurora kinases for selective isoform inhibition	European Journal of Medicinal Chemistry. 2018 May 10;151:533-545.

顯示項目1-10 / 21. (共3頁) 1 2 3 > >> 每頁顯示[10|25|50]項目